InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Coelho Rogerio Vivaldi
2 Jul 2026
Director
Sold on a plan
3,000
$40.00
$120.00K
Stephanie Okey
17 Jun 2026
Director
Sold on a plan
608
$36.22
$22.02K
Stephanie Okey
17 Jun 2026
Director
Sold on a plan
6,292
$35.62
$224.12K
Richard Scott Struthers
16 Mar 2026
President & CEO
Sold on a plan
8,785
$37.77
$331.81K
Richard Scott Struthers
16 Mar 2026
President & CEO
Sold on a plan
13,196
$37.11
$489.70K
Stephen F. Betz
16 Mar 2026
Chief Scientific Officer
Sold on a plan
4,241
$37.77
$160.18K
Stephen F. Betz
16 Mar 2026
Chief Scientific Officer
Sold on a plan
6,371
$37.11
$236.43K
Jeff E. Knight
16 Mar 2026
Chief Operating Officer
Sold on a plan
3,961
$37.77
$149.61K
Jeff E. Knight
16 Mar 2026
Chief Operating Officer
Sold on a plan
5,950
$37.11
$220.80K
Coelho Rogerio Vivaldi
12 Mar 2026
Director
Sold on a plan
523
$36.77
$19.23K
Coelho Rogerio Vivaldi
12 Mar 2026
Director
Sold on a plan
4,477
$36.08
$161.53K
Tobin Schilke
3 Mar 2026
Chief Financial Officer
Sold on a plan
6,713
$39.67
$266.30K
Stephanie Okey
3 Mar 2026
Director
Sold on a plan
3,000
$39.67
$119.01K
Show all 23 transactions →

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 3
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,245,150
History held since 20 Jul 2018